Prothena Corporation plc Logo

Email this page: News Release

Prothena Presents New Data from Phase 1/2 Study of NEOD001 Demonstrating Improvements in Three Organ Systems in Previously-Treated Patients with AL Amyloidosis

For security reasons, registration is required before you can use this feature.
* Indicates required field